Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic Treatments
NCT01086280
·
clinicaltrials.gov ↗
COMPLETED
Status
113505
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Sponsor
AstraZeneca
Collaborators
[object Object]
[object Object]